Diabetes in Primary Care - Improving Classification

NCT ID: NCT06711718

Last Updated: 2025-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

45 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-25

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the clinical utility and acceptability to patients and practitioners of running diabetes classification algorithms on primary care data to help improve diagnosis of diabetes subtypes in adults diagnosed with diabetes under the age of 50. The outputs from this research will help provide initial data on how best to use these algorithms in primary care and the optimal design of a decision support tool that could be taken forward to a full trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Part 1:

Using a successful approach from previous research, and experience from existing online diabetes classification calculators, we will test the feasibility of developing a decision support tool that would run the algorithms in these calculators on electronic healthcare record data at participating GP sites. We will work with a company that will develop a decision support tool that will search and extract relevant healthcare data in GP systems, run our algorithms on these data, and produce a display, highlighting patient records where there is a potential misclassification of diabetes and/or records where there are potential data quality issues (e.g. mis-coding or missing information). The decision support tool will only run on extracted data (rather than being embedded in the GP system).

Participating GP sites will be offered an introductory education session on classification of diabetes subtypes and identification of MODY (Maturity Onset Diabetes of the Young) and training on running and interpreting the decision tool.

On receipt of the outputs from the decision support tool, practice staff will be advised to review the records of potentially misclassified patients to explore any mis-codings and to consider further testing/referrals as relevant and in line with the standard clinical care pathway for diabetes.

At the end of the study, the data extraction/decision support tool may be re-run to determine whether there have been changes and whether additional testing (eg C-peptide or islet autoantibody) or referral to a diabetes specialist team has been carried out.

Part 2:

To assess the acceptability of the diabetes classification tools to potential users, and to consider how best to implement them in clinical practice long term for maximum benefit, we will explore the views and experiences of general practice teams and people with diabetes on the use of the diabetes classification tools.

A sample of clinical and admin staff at participating GP sites, and diabetes patients flagged by the tool as misclassified, will be invited to take part in a semi-structured interview about their views \& experience.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients qualitative interviews

1. Patients reviewed by their GP as a result of Stage 1 (running of tool) are invited to a qualitative interview.
2. Consenting participants interviewed by the research team.
3. Information used to assess the impact and potential benefit of using the diabetes classification tool in general practice.

Qualitative interview (patients)

Intervention Type OTHER

Qualitative interviews to be carried out by an experienced researcher with patients who have had their diabetes diagnosis reviewed as a result of the running of the tool.

Practice staff qualitative interviews

1. Practice staff (clinical and administrative) who have been involved in Stage 1 (running of tool) are invited to a qualitative interview.
2. Consenting participants interviewed by the research team.
3. Information used to assess the impact and potential benefit of using the diabetes classification tool in general practice.

Qualitative interview (staff)

Intervention Type OTHER

Qualitative interviews to be carried out by an experienced researcher with practice staff who have run the tool and reviewed patients flagged by the tool.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Qualitative interview (patients)

Qualitative interviews to be carried out by an experienced researcher with patients who have had their diabetes diagnosis reviewed as a result of the running of the tool.

Intervention Type OTHER

Qualitative interview (staff)

Qualitative interviews to be carried out by an experienced researcher with practice staff who have run the tool and reviewed patients flagged by the tool.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients

* Able to give written informed consent
* 18 years of age or over at the time of study participation
* Diabetes diagnosed at or under the age of 50
* Registered with a participating GP practice
* Sufficient understanding of the English Language to enable completion of the interview

Staff

* Able to give written informed consent
* 18 years of age or over
* Working at a participating General Practice and directly involved with the study procedures (eg running the decision support tool, responsibility for clinical care of diabetes patients)

Exclusion Criteria

Patients

* Unable to give written informed consent
* Under 18 years of age
* No diabetes or diabetes diagnosed over the age of 50.
* Not registered with a participating GP practice
* Insufficient understanding of the English Language to enable interview completion
* Have an opt-out code where patient has declined electronic medical records examined
* Considered by their General Practitioner(s) to be inappropriate to recruit due to psycho-social reasons, participating in another related clinical trial or significant health reasons, e.g. terminal illness/diagnosis.

Staff

* Unable to give written informed consent
* Under 18 years of age
* General Practice staff not involved with the study procedures.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Bristol

OTHER

Sponsor Role collaborator

University of Nottingham

OTHER

Sponsor Role collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

Sponsor Role collaborator

University of Exeter

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Beverley Shields, Professor

Role: PRINCIPAL_INVESTIGATOR

University of Exeter

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tamar Valley Health

Plymouth, Cornwall, United Kingdom

Site Status RECRUITING

Ivybridge Medical Practice (Beacon Medical Group)

Ivybridge, Devon, United Kingdom

Site Status NOT_YET_RECRUITING

Roborough Surgery

Plymouth, Devon, United Kingdom

Site Status NOT_YET_RECRUITING

Pathfields Medical Group

Plymouth, Devon, United Kingdom

Site Status NOT_YET_RECRUITING

Plympton Health Centre (Beacon Medical Group)

Plymouth, Devon, United Kingdom

Site Status NOT_YET_RECRUITING

Chaddlewood Surgery (Beacon Medical Group)

Plymouth, Devon, United Kingdom

Site Status NOT_YET_RECRUITING

Hucknall Road Medical Centre

Nottingham, Nottinghamshire, United Kingdom

Site Status RECRUITING

Parkside Medical Practice

Nottingham, Nottinghamshire, United Kingdom

Site Status RECRUITING

Chilwell Valley and Meadows Practice

Nottingham, Nottinghamshire, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Maddy Geen

Role: CONTACT

01392 408195

Anita Hill

Role: CONTACT

01392 408195

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Laura-Ann Bruton

Role: primary

01579 382666 or 01822 832641

Alex Trotman

Role: primary

01752 346634

Emma Roberts

Role: primary

Denise Hall

Role: primary

01752 675832

Alex Trotman

Role: primary

01752 346634

Alex Trotman

Role: primary

01752 346634

Gemma Kirkwood

Role: primary

0115 9606652

Benjamin Moorhouse

Role: primary

Ed Longridge

Role: primary

0115 8835552

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-23-18

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.